These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27379565)

  • 1. Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma.
    Beaven AW; Samsa G; Zimmerman S; Smith SK
    Cancer Invest; 2016 Jul; 34(6):279-85. PubMed ID: 27379565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study.
    Kang D; Cho J; Kim IR; Kim MK; Kim WS; Kim SJ
    Cancer Res Treat; 2018 Oct; 50(4):1051-1063. PubMed ID: 29121713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma.
    Blaes AH; Ma L; Zhang Y; Peterson BA
    Leuk Lymphoma; 2011 Nov; 52(11):2105-10. PubMed ID: 21740095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism.
    Kiserud CE; Seland M; Holte H; Fosså A; Fosså SD; Bollerslev J; Bjøro T; Loge JH
    Acta Oncol; 2015 Jan; 54(1):49-59. PubMed ID: 25140862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with low-grade non-Hodgkin's lymphoma.
    Webster K; Cella D
    Oncology (Williston Park); 1998 May; 12(5):697-714; discussion 714, 717, 721. PubMed ID: 9597680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual problems in male vs. female non-Hodgkin lymphoma survivors: prevalence, correlates, and associations with health-related quality of life.
    Kim IR; Kim SH; Ok ON; Kim SH; Lee S; Choi E; Kim SJ; Yoon DH; Lee MH
    Ann Hematol; 2017 May; 96(5):739-747. PubMed ID: 28184983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic literature review of health-related quality of life among aggressive non-Hodgkin lymphoma survivors.
    Lin VW; Blaylock B; Epstein J; Purdum A
    Curr Med Res Opin; 2018 Aug; 34(8):1529-1535. PubMed ID: 29741105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cancer and quality of life for post-treatment non-Hodgkin lymphoma survivors.
    Smith SK; Crespi CM; Petersen L; Zimmerman S; Ganz PA
    Psychooncology; 2010 Dec; 19(12):1259-67. PubMed ID: 20099255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
    Xavier AC; Armeson KE; Hill EG; Costa LJ
    Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
    Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
    Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory path model of the relationships between positive and negative adaptation to cancer on quality of life among non-Hodgkin lymphoma survivors.
    Bryant AL; Smith SK; Zimmer C; Crandell J; Jenerette CM; Bailey DE; Zimmerman S; Mayer DK
    J Psychosoc Oncol; 2015; 33(3):310-31. PubMed ID: 25751114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring health-related quality of life among non-Hodgkin's lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand.
    Lekdamrongkul P; Pongthavornkamol K; Molassiotis A; Sriyuktasuth A; Siritanaratkul N; Chansatitporn N
    Support Care Cancer; 2021 Nov; 29(11):6511-6522. PubMed ID: 33909148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reallocating time to sleep, sedentary, and active behaviours in non-Hodgkin lymphoma survivors: associations with patient-reported outcomes.
    Vallance JK; Buman MP; Lynch BM; Boyle T
    Ann Hematol; 2017 May; 96(5):749-755. PubMed ID: 28197722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent indolent NHL: new strategies for treatment.
    Amen K
    ONS Connect; 2007; 22(8 Suppl):57-8. PubMed ID: 17824567
    [No Abstract]   [Full Text] [Related]  

  • 16. Demographic and disease characteristics associated with non-hodgkin lymphoma survivors' quality of life: does age matter?
    Leak A; Smith SK; Crandell J; Jenerette C; Bailey DE; Zimmerman S; Mayer DK
    Oncol Nurs Forum; 2013 Mar; 40(2):157-62. PubMed ID: 23448740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in quality of life between non-Hodgkin's lymphoma survivors meeting and not meeting public health exercise guidelines.
    Vallance JK; Courneya KS; Jones LW; Reiman T
    Psychooncology; 2005 Nov; 14(11):979-91. PubMed ID: 15744764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis.
    Migdady Y; Salhab M; Dang NH; Markham MJ; Olszewski AJ
    Leuk Lymphoma; 2016; 57(3):676-84. PubMed ID: 26428541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening Quality of Life in Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients in Active Surveillance: A 12-Month Longitudinal Study.
    Trevino KM; Martin P; Chen Z; Leonard JP
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):82-88. PubMed ID: 34479847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries.
    Avivi I; Farbstein D; Brenner B; Horowitz NA
    Blood Rev; 2014 Sep; 28(5):213-20. PubMed ID: 25108745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.